Telehealth Allied Health Care With People Who Have Parkinson's Disease Living in Rural Nevada and Wyoming

2018-01-03 13:38:10 | BioPortfolio

Published on BioPortfolio: 2018-01-03T13:38:10-0500

Clinical Trials [4226 Associated Clinical Trials listed on BioPortfolio]

Development of Software to Provide the SpeechVive Device Via the Internet

Telehealth, increasingly recognized in the neurology field as a solution to access issues for people with Parkinson's disease, improves access to speech therapy, particularly those living ...

Detecting Parkinson's Disease Through Speech Analysis

Speech is an important indicator of motor function and movement coordination and can be extremely sensitive to involvement in the course of neurologic diseases. The aim of this project is ...

Voice Therapy in Parkinson Disease

The purpose of this study is to evaluate the impact of a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) on voice/speech treatment in people with Pa...

Improve Speech Using an in-the-Ear Device in Parkinson's Disease

This project will systematically examine the therapeutic effect of altered auditory feedback provided by the in-the-ear device on the speech impairments in patients with Parkinson's diseas...

Singing in Groups for Parkinson's Disease; A Pilot Study of Group Singing Therapy for PD-related Voice/Speech Impairment

This study will compare group singing to group speech therapy without singing. You may be eligible for this study if you have been diagnosed with PD for one year or more and you have a qu...

PubMed Articles [31412 Associated PubMed Articles listed on BioPortfolio]

Use of a Telehealth System to Enhance a Home Exercise Program for a Person With Parkinson Disease: A Case Report.

This case addresses feasibility of a home-based telehealth system to enhance home exercise program (HEP) adherence for a patient with Parkinson disease (PD). We describe START-System for Technology-Au...

Delayed Administration and Contraindicated Drugs Place Hospitalized Parkinson's Disease Patients at Risk.

Inpatients with Parkinson's disease require precise medication management.

Degradation of Neuronal Encoding of Speech in the Subthalamic Nucleus in Parkinson's Disease.

Most of the patients with Parkinson's disease suffer from speech disorders characterized mainly by dysarthria and hypophonia.

Frequency of speech disruptions in Parkinson's Disease and developmental stuttering: A comparison among speech tasks.

To analyze the frequency of speech disruptions across different speech tasks, comparing the performance of individuals with Parkinson's Disease (PD) and DS.

The need for mapping personal goals to exercise dosage in community-based exercise programs for people with Parkinson's disease.

Community-based exercise can support long-term management of Parkinson's disease, although it is not known if personal goals are met in these programs. The objectives of this study were to: (1) examin...

Medical and Biotech [MESH] Definitions

Assistance in managing and monitoring drug therapy for patients receiving treatment for cancer or chronic conditions such as asthma and diabetes, consulting with patients and their families on the proper use of medication; conducting wellness and disease prevention programs to improve public health; overseeing medication use in a variety of settings.

Treatment for individuals with speech defects and disorders that involves counseling and use of various exercises and aids to help the development of new speech habits.

Proteins associated with sporadic or familial cases of PARKINSON DISEASE.

A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.

Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE.

More From BioPortfolio on "Telehealth Allied Health Care With People Who Have Parkinson's Disease Living in Rural Nevada and Wyoming"

Quick Search


Searches Linking to this Trial